Growth Inhibition of Tumor by Recombinant SEA / 中国肿瘤生物治疗杂志
Chinese Journal of Cancer Biotherapy
;
(6)1995.
Artículo
en Chino
| WPRIM
| ID: wpr-584913
ABSTRACT
Objective:
To evaluate the antitumor activity of recombinant SEA for therapy of B16 melanoma established in C57BL/6 mice.Methods:
C57BL/6 mice with melanoma were treated with the purified rSEA. The tumors were isolated and weighted.Results:
Tumor growth was apparently inhibited by rSEA at high, middle, and low doses intraperitone-ally, whose inhibition ratio were 79.3% , 75.6 % and 73. 8% respectively. rSEA treatment in situ could inhibit tumor growth more effectively(90.6% ). Further study showed that numerous CD8+ and CD4+ T cell were infiltrated in tumor tissues, which were consistent with tumor growth inhibition induced by rSEA.Conclusions:
rSEA could inhibit tumor growth effectively, especially the treatment in situ. This study paves the way for tumor immunotherapy with targeted SEA.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Chinese Journal of Cancer Biotherapy
Año:
1995
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS